Cleared Traditional

K033978 - ADAM

K033978 is an FDA 510(k) clearance for ADAM, manufactured by Astro-Med, Inc.. The device is a Class 2 Neurology device with product code GWQ cleared through the Traditional 510(k) pathway after a 57-day FDA review.

Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Feb 2004
Decision
57d
Days
Class 2
Risk

K033978 is an FDA 510(k) clearance for the ADAM. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Astro-Med, Inc. (West Warwick, US). The FDA issued a Cleared decision on February 18, 2004 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K033978

510(k) Number K033978 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 23, 2003
Decision Date February 18, 2004
Days to Decision 57 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 149d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWQ Device Classification - Class 2, Special Controls

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 188
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K033978.
GEODESIC EEG SYSTEM SERIES 100
K033399 · Electrical Geodesics, Incorporated · Aug 2004
ACTIGRAPH, MODEL AM7164-2.2 AND ACTIGRAPH WITH EXTENDED MEMORY, MODEL AM71256
K040554 · Manufacturing Technology, Inc. · Jul 2004
EMU128S, MODEL EX-NW-128S
K040360 · Excel Tech. , Ltd. · Mar 2004
SYNAMPS2
K023771 · Neuroscan · Feb 2003
EPOCH XP NEUROLOGICAL WORKSTATION
K022785 · Axon Systems, Inc. · Oct 2002
96 CHANNEL EEG HEADBOX MODEL EMU96
K021599 · Excel Tech. , Ltd. · Aug 2002